Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma
Martina Ruscelli,Thais Maloberti,Angelo Gianluca Corradini,Francesca Rosini,Giulia Querzoli,Marco Grillini,Annalisa Altimari,Elisa Gruppioni,Viviana Sanza,Alessia Costantino,Riccardo Ciudino,Matteo Errani,Alessia Papapietro,Sara Coluccelli,Daniela Turchetti,Martina Ferioli,Susanna Giunchi,Giulia Dondi,Marco Tesei,Gloria Ravegnini,Francesca Abbati,Daniela Rubino,Claudio Zamagni,Emanuela D'Angelo,Pierandrea De Iaco,Donatella Santini,Claudio Ceccarelli,Anna Myriam Perrone,Giovanni Tallini,Dario de Biase,Antonio De Leo
DOI: https://doi.org/10.3390/jpm13050723
2023-04-25
Abstract:The molecular characterization of endometrial carcinoma (EC) has recently been included in the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated molecular and pathologic risk stratification in the clinical practice and the relevance of pathologic parameters in predicting prognosis in each EC molecular subgroup. ECs were classified using immunohistochemistry and next-generation sequencing into the four molecular classes: POLE mutant (POLE), mismatch repair deficient (MMRd), p53 mutant (p53abn), and no specific molecular profile (NSMP). According to the WHO algorithm, 219 ECs were subdivided into the following molecular subgroups: 7.8% POLE, 31% MMRd, 21% p53abn, 40.2% NSMP. Molecular classes as well as ESGO/ESTRO/ESP 2020 risk groups were statistically correlated with disease-free survival. Considering the impact of histopathologic features in each molecular class, stage was found to be the strongest prognostic factor in MMRd ECs, whereas in the p53abn subgroup, only lymph node status was associated with recurrent disease. Interestingly, in the NSMP tumor, several histopathologic features were correlated with recurrence: histotype, grade, stage, tumor necrosis, and substantial lymphovascular space invasion. Considering early-stage NSMP ECs, substantial lymphovascular space invasion was the only independent prognostic factor. Our study supports the prognostic importance of EC molecular classification and demonstrated the essential role of histopathologic assessment in patients' management.